C3 and Alzheimer disease: Subsequent studies in murine models of Alzheimer’s disease supported the hypothesis; pathological synapse loss was reduced by inhibiting or deleting C1q, C3 or CR3, firmly implicating complement activation and opsonisation in synaptic elimination in the disease [18].